BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 2, 2012
View Archived Issues
New PAK-4 inhibitor under development to treat gastric cancers
Read More
Scientists discover novel neurotrophic drug to treat cognitive decline
Read More
Findings presented from two phase III trials of Lu-AA-21004 in GAD
Read More
Kinetin shows promise to treat familial dysautonomia
Read More
Astellas Pharma presents new drug for treatment of transplant rejection
Read More
Toray divulges new inhibitors of 11-beta-HSD1
Read More
New camptothecin derivatives designed in Spain
Read More
IntraCellular Therapies claims novel phosphodiesterase 1B inhibitors
Read More
Novel phosphodiesterase inhibitors disclosed
Read More
New monoglyceride lipase inhibitors prepared by Sanofi
Read More
Syndax Pharmaceuticals designs new azacitidine prodrugs
Read More
Roche presents novel drugs for Parkinson's disease
Read More
FDA advisory committee to review Xgeva sBLA
Read More
Apricus Biosciences finalizes acquisition
Read More
BG Medicine files application for second cardiovascular diagnostic test
Read More
Marshall Edwards raises funds to advance lead oncology candidates
Read More
Opko Health completes acquisition
Read More
Symmetry Medical acquires surgical instruments business
Read More
Amgen moves AMG-172 to clinic
Read More
MethylGene recruiting participants in phase II MGCD-290 study
Read More
Gene therapy for wet AMD enters phase I/II testing
Read More
Clinical trial application submitted in Russia for AT-001
Read More
Clinical development ZP-1846 advances
Read More
FDA expands indication of Prevnar 13
Read More
Prima BioMed provides update on preclinical testing of Cripto-1 immunotherapy
Read More